The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.
The votes followed an emotional floor debate on abortion — and an unusual parliamentary tussle over whether the Democratic leader had violated the chamber’s decorum,
Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback